OPCIE Advisory Board
Elizabeth Hutt Pollard
Secretary of Science and Innovation
Governor Kevin Stitt appointed Pollard as Secretary of Science and Innovation on June 29, 2020. In this position, Pollard places a strategic emphasis on enabling science and innovation to impact health, commerce, and stem education for Oklahoma. Prior to her appointment by Governor Stitt, Pollard served as Deputy Secretary of Science and Innovation under Secretary Kayse Shrum.
In addition to her cabinet role, Pollard is Executive Chair of Applied Silver, a materials science health-tech company located in Silicon Valley addressing infection control and antibiotic stewardship. She is a C-Suite veteran and has extensive global experience scaling businesses, building commercial and academic partnerships, and bringing to market highly specialized technology and solutions, including software and microfluidics, for healthcare, pharma, diagnostics, and life science research. Because of her expertise in genomic tools and test development, Pollard serves as an advisor to the Oklahoma Department of Health’s COVID-19 testing response and has been instrumental in fostering commercial technology partnerships for the State’s COVID-19 testing.
In addition, Pollard advises several early stage healthcare companies and has held board director roles in public, private and non-profit organizations. Most recently, Pollard has been named to the 2020-2023 YPO Global Board of Directors and serves on the finance committee. YPO’s 29,000 executive leaders represent businesses that together account for the world’s 3rd largest GDP.
Pollard is a past member of the National Association of Corporate Directors (NACD), Women Corporate Directors (WCD), and the American Chemical Society (ACS).
Pollard moved to Oklahoma in 2018 from California because of her appreciation for the State’s infrastructure, culture, and values. She and her husband, Dennis, reside in Edmond. She is a native Michigander and received her BA in Chemistry from Michigan State University and MS in Administration from Central Michigan University.
James W. Curran, M.D., MPH
Dean, Rollins School of Public Health, Emory University
Dr. Curran is the Dean of the Rollins School of Public Health at Emory University and a Professor of Epidemiology. Graduating from the University of Notre Dame, he received his M.D. from the University of Michigan and a Master of Public Health from Harvard University.
In 1981 Dr. Curran coordinated the task force on acquired immune deficiency syndrome (AIDS) at the Centers for Disease Control and Prevention (CDC) and then led the HIV/AIDS Division. While at the CDC, he attained the rank of the Assistant Surgeon General.
He is a fellow of the American Epidemiologic Society, the American College of Preventive Medicine, and the Infectious Diseases Society of America and was elected to the Institute of Medicine of the National Academy of Sciences in 1993. He was given the Surgeon General's Medal of Excellence in 1996 and the John Snow Award from the American Public Health Association in 2003.
Dr. Curran is an adjunct Professor of Medicine and Nursing, and Co-Director of the Emory Center for AIDS Research. He is immediate past chair of the board on Population Health and Public Health Practice of the Institute of Medicine and serves on the Board of Directors of the Association of Schools and Programs of Public Health. Additionally, he holds an endowed chair known as the James W. Curran Dean of Public Health.
Julie Ledgerwood, D.O.
Deputy Director and Chief Medical Officer Vaccine Research Center National Institute of Allergy and Infectious Diseases, National Institutes of Health
Julie E. Ledgerwood, D.O., is the Chief Medical Officer and Chief of the Clinical Trials Program for the Vaccine Research Center, NIAID.
Dr. Ledgerwood has 16 years of clinical research experience and is responsible for VRC clinical research strategic planning, research activities, regulatory strategy, compliance, and regulatory operations. She leads a team of 64 clinical researchers and regulatory experts and has conducted more than 60 Phase I to IIb clinical trials studying vaccines and monoclonal antibodies targeting pathogens such as HIV, influenza, Ebola, Malaria, Chikungunya, and Zika in over 13 countries. She has authored more than 85 publications and received numerous awards for her work.
Dr. Ledgerwood completed her internship at Oklahoma State University Medical Center, residency in internal medicine at Johns Hopkins Bayview Medical Center in Baltimore and fellowship in allergy and immunology at NIH.
She is board-certified in allergy and immunology by the American Board of Allergy and Immunology.
She earned her degree in osteopathic medicine from OSU College of Osteopathic Medicine.
Barry Pollard, M.D.
Dr. Pollard graduated from OSU with a bachelor’s degree in biochemistry in 1973 before earning his doctorate of medicine in 1977 from the University of Oklahoma.
For more than three decades, Pollard has been a neurosurgeon in Enid, Oklahoma, where his practice is based.
In addition to running a successful medical practice, Dr. Pollard also owns P&K Equipment, the largest John Deere dealership in Oklahoma. Since purchasing his first dealership in 1983, the company now has 27 dealerships in Oklahoma, Arkansas, and Iowa.
Dr. Pollard serves on the board of the Oklahoma Medical Research Foundation and the American Angus Association. He was inducted into the OSU Alumni Association Hall of Fame in 2017 and into the Oklahoma Agriculture Hall of Fame in 2020.